| RS2514644127 |
DLL3
|
Health Risk |
Pathogenic |
— |
| RS2514644148 |
CNOT3
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with speech delay, autism |
| RS2514644262 |
PNKP
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 12 |
| RS2514646442 |
DLL3
|
Health Risk |
Pathogenic |
— |
| RS2514646544 |
SLC5A5
|
Health Risk |
Pathogenic |
— |
| RS2514646705 |
SLC5A5
|
Health Risk |
Pathogenic |
— |
| RS2514646860 |
DLL3
|
Health Risk |
Pathogenic |
— |
| RS2514647017 |
CSNK2A1
|
Health Risk |
Pathogenic |
Okur-Chung neurodevelopmental syndrome, Okur-Chung neurodevelopmental syndrome |
| RS2514647160 |
CSNK2A1
|
Health Risk |
Pathogenic |
— |
| RS2514649158 |
DLL3
|
Health Risk |
Pathogenic |
Spondylocostal dysostosis 1, autosomal recessive |
| RS2514649349 |
DLL3
|
Health Risk |
Pathogenic |
— |
| RS2514649574 |
DLL3
|
Health Risk |
Pathogenic |
— |
| RS2514651982 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2514652531 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2514654539 |
RYR1
|
Health Risk |
Likely pathogenic |
Central core myopathy, Central core myopathy |
| RS2514654709 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2514662565 |
CSNK2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2514672757 |
CSNK2A1
|
Health Risk |
Pathogenic |
— |
| RS2514672851 |
CSNK2A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Okur-Chung neurodevelopmental syndrome, Intellectual disability |
| RS2514672857 |
CSNK2A1
|
Health Risk |
Likely pathogenic |
Okur-Chung neurodevelopmental syndrome, Okur-Chung neurodevelopmental syndrome |
| RS2514673013 |
CSNK2A1
|
Health Risk |
Pathogenic |
— |
| RS2514673677 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Malignant hyperthermia |
| RS2514674151 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2514674870 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2514677222 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2514677532 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2514678035 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2514678371 |
RYR1
|
Health Risk |
Pathogenic/Likely pathogenic |
RYR1-related disorder, Congenital multicore myopathy with external ophthalmoplegia |
| RS2514679695 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2514679850 |
CSNK2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2514680874 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2514680973 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2514681064 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2514681321 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2514682048 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2514682490 |
RYR1
|
Health Risk |
Likely pathogenic |
Malignant hyperthermia, susceptibility to |
| RS2514689974 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2514694950 |
RYR1
|
Health Risk |
Likely pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2514697058 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS2514697373 |
SMARCA4
|
Health Risk |
Pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS2514699870 |
NKX2-2
|
Health Risk |
Likely pathogenic |
— |
| RS2514701114 |
FERMT1
|
Health Risk |
Likely pathogenic |
— |
| RS2514703437 |
FERMT1
|
Health Risk |
Pathogenic |
— |
| RS2514706791 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2514723064 |
FERMT1
|
Health Risk |
Pathogenic |
— |
| RS2514723164 |
FERMT1
|
Health Risk |
Pathogenic |
— |
| RS2514729323 |
TMEM147
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with facial dysmorphism, absent language |
| RS2514730089 |
RYR1
|
Health Risk |
Likely pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2514731335 |
TMEM147
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with facial dysmorphism, absent language |
| RS2514731343 |
TMEM147
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with facial dysmorphism, absent language |
| RS2514732396 |
TMEM147
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with facial dysmorphism, absent language |
| RS2514732447 |
TMEM147
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with facial dysmorphism, absent language |
| RS2514732927 |
TMEM147
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with facial dysmorphism, absent language |
| RS2514738228 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Malignant hyperthermia, susceptibility to |
| RS2514738308 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2514740325 |
RYR1
|
Health Risk |
Likely pathogenic |
— |
| RS2514746358 |
CACNA1C
|
Health Risk |
Likely pathogenic |
Timothy syndrome, Timothy syndrome |
| RS2514748395 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2514748917 |
RYR1
|
Health Risk |
Likely pathogenic |
Central core myopathy, Central core myopathy |
| RS2514752302 |
RYR1
|
Health Risk |
Likely pathogenic |
Central core myopathy, Central core myopathy |
| RS2514753529 |
CACNA1C
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with hypotonia, language delay |
| RS2514759456 |
IDH3B
|
Health Risk |
Pathogenic |
— |
| RS2514760524 |
IDH3B
|
Health Risk |
Likely pathogenic |
— |
| RS2514769253 |
IDH3B
|
Health Risk |
Likely pathogenic |
— |
| RS2514778854 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2514779743 |
RYR1
|
Health Risk |
Likely pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2514782731 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Malignant hyperthermia, susceptibility to |
| RS2514783845 |
PLCB1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 12 |
| RS2514785213 |
SNAP25
|
Health Risk |
Likely pathogenic |
Congenital myasthenic syndrome 18, Congenital myasthenic syndrome 18 |
| RS2514799008 |
PAX1
|
Health Risk |
Pathogenic |
— |
| RS2514799393 |
PAX1
|
Health Risk |
Pathogenic |
— |
| RS2514799744 |
PAX1
|
Health Risk |
Pathogenic |
— |
| RS2514799919 |
PRX
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS2514800211 |
PRX
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS2514800557 |
PRX
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS2514803170 |
PRX
|
Health Risk |
Likely pathogenic |
— |
| RS2514803553 |
PRX
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS2514803711 |
PRX
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS2514804225 |
PRX
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS2514804861 |
PRX
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS2514806102 |
PRX
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS2514806399 |
PRX
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS2514807382 |
PRX
|
Health Risk |
Likely pathogenic |
PRX-related disorder, PRX-related disorder |
| RS2514810724 |
SMARCA4
|
Health Risk |
Likely pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS2514813303 |
FOXA2
|
Health Risk |
Likely pathogenic |
Congenital syndromic hypopituitarism, Congenital syndromic hypopituitarism |
| RS2514817991 |
PRX
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS2514828064 |
SMARCA4
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 16 |
| RS2514833199 |
SNAP25
|
Health Risk |
Likely pathogenic |
Presynaptic congenital myasthenic syndrome, Presynaptic congenital myasthenic syndrome |
| RS2514836751 |
KIZ
|
Health Risk |
Likely pathogenic |
— |
| RS2514848897 |
SLC52A3
|
Health Risk |
Pathogenic |
Brown-Vialetto-van Laere syndrome 1, Brown-Vialetto-van Laere syndrome 1 |
| RS2514849071 |
SLC52A3
|
Health Risk |
Likely pathogenic |
Brown-Vialetto-van Laere syndrome 1, Brown-Vialetto-van Laere syndrome 1 |
| RS2514849190 |
SLC52A3
|
Health Risk |
Likely pathogenic |
Auditory neuropathy, Auditory neuropathy |
| RS2514853132 |
SNAP25
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myasthenic syndrome 18, Inborn genetic diseases |
| RS2514853298 |
IL12RB1
|
Health Risk |
Likely pathogenic |
Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency, Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency |
| RS2514853315 |
SNAP25
|
Health Risk |
Likely pathogenic |
Congenital myasthenic syndrome 18, Congenital myasthenic syndrome 18 |
| RS2514853352 |
SLC52A3
|
Health Risk |
Pathogenic |
Brown-Vialetto-van Laere syndrome 1, Brown-Vialetto-van Laere syndrome 1 |
| RS2514853451 |
SNAP25
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 18, Congenital myasthenic syndrome 18 |
| RS2514853517 |
SNAP25
|
Health Risk |
Likely pathogenic |
Congenital myasthenic syndrome 18, Congenital myasthenic syndrome 18 |
| RS2514853554 |
SNAP25
|
Health Risk |
Likely pathogenic |
Congenital myasthenic syndrome 18, Congenital myasthenic syndrome 18 |
| RS2514854877 |
RIN2
|
Health Risk |
Pathogenic |
— |